Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ALT stock hub

Altimmune, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

600.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALT

In the news

Latest news · ALT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-50.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-30.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001326190
Company name	Altimmune, Inc.
Country	United States
Country code	US
Cusip	02155H200
Employees	57
Employees Change	-2%
Employees Change Percent	-3.39
Enterprise value	$362.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US02155H2004
Last refreshed	2026-05-10
Market cap	$600.1M
Market cap category	Small-Cap
Price	$3.09
Price currency	USD
Rev Per Employee	719.3x
Sector	Healthcare
Sic	2834
Symbol	ALT
Website	https://altimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.68%
EV/Sales	8,836.78x
FCF yield	-11.26%
P/B ratio	1.52x
P/S ratio	14,636x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-66.4M
Net Income	$-88.1M
Net Income Growth Years	1%
Pretax Margin	-216,521.95%
Profit Per Employee	$-1.5M
ROA	-28.17
Roa5y	-27.72
ROCE	-35.67
ROE	-50.57
Roe5y	-49.36
ROIC	-30.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.37%
Cagr3y	-14.48%
Cagr5y	-25.29%
EPS Growth Quarters	6
EPS Growth Years	4
Revenue Growth	105x
Revenue Growth Q	420x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth5 Y	-65.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$279.9M
Cash	$273.5M
Current Assets	$278.2M
Current Liabilities	$15M
Debt	$35.7M
Debt Equity	$0.16
Equity	$224.9M
Interest Coverage	-57.76
Liabilities	$55M
Long Term Assets	$1.7M
Long Term Liabilities	$40M
Net Cash	$237.8M
Net Cash By Market Cap	$39.62
Net Cash Growth	82.6%
Net Debt Equity	$-1.06
Tangible Book Value	$224.9M
Tangible Book Value Per Share	$2.03
WACC	5.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.55
Net Working Capital	$-10M
Quick ratio	18.35
Working Capital	$263.2M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.35%
200-day SMA	4.01
3Y total return	-37.45%
50-day SMA	3.35
50-day SMA vs 200-day SMA	50under200
5Y total return	-76.71%
All Time High	237.3
All Time High Change	-98.7%
All Time High Date	2017-05-05
All Time Low	1.51
All Time Low Change	104.64%
All Time Low Date	2019-11-19
ATR	0.2
Beta	0.17
Beta1y	0.27
Beta2y	1.56
Ch YTD	-14.4
High	3.11
High52	7.73
High52 Date	2025-06-25
High52ch	-60.03%
Low	3.01
Low52	2.56
Low52 Date	2026-05-01
Low52ch	20.7%
Ma50ch	-7.71%
Premarket Change Percent	0.66
Premarket Price	$3.06
Premarket Volume	11,384
Price vs 200-day SMA	-22.85%
RSI	47.97
RSI Monthly	42.54
RSI Weekly	40.65
Sharpe ratio	-0.08x
Sortino ratio	-0.05
Total Return	-24.08%
Tr YTD	-14.4
Tr1m	-8.58%
Tr1w	9.57%
Tr3m	-36.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$17.25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.25
Earnings Revenue Estimate	1,000x
Earnings Revenue Estimate Growth	-80x
Operating Income	$-94.5M
Operating margin	-230,461
Price target	$17.67
Price Target Change	$472
Price Target Change Top	$458

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	163,868,213%
Float Percent	84.38%
Net Borrowing	35,000,000
Shares Insiders	0.47%
Shares Institutions	38.94%
Shares Out	194,199,358
Shares Qo Q	12.52%
Shares Yo Y	24.08%
Short Float	17.54%
Short Ratio	9.38
Short Shares	14.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-83.6M
Average Volume	5,528,899.2x
Bv Per Share	2.03
CAPEX	$-11,000
Ch1m	-8.58
Ch1w	9.57
Ch1y	-42.35
Ch3m	-36.55
Ch3y	-37.45
Ch5y	-76.71
Ch6m	-24.82
Change	1.64%
Change From Open	0.65
Close	3.04
Days Gap	0.99
Depreciation Amortization	112,000
Dollar Volume	8,831,986.3
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-94.5M
EBITDA	$-94.4M
EPS	$-1
F Score	3
FCF	$-67.5M
FCF EV Yield	-18.64x
FCF Per Share	$-0.35
Financing CF	206,842,000
Fiscal Year End	December
Founded	1,997
Income Tax	$-681,000
Investing CF	-132,473,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2018-09-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-06
Ma150	4.1
Ma150ch	-24.71%
Ma20	3.11
Ma20ch	-0.58%
Net CF	6,834,000
Next Earnings Date	2026-05-13
Open	3.07
Optionable	Yes
Position In Range	80
Post Close	3.09
Postmarket Change Percent	-0.32
Postmarket Price	$3.08
Ppne	1,737,000
Pre Close	3.04
Price Date	2026-05-08
Ptbv Ratio	2.67
Relative Volume	0.52x
Revenue	41,000x
SBC By Revenue	39,209.76x
Share Based Comp	16,076,000
Tax By Revenue	-1,660.98x
Tr6m	-24.82%
Us State	Maryland
Volume	2,858,248
Z Score	1.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALT pay a dividend?

Capital-return profile for this ticker.

Performance

ALT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.9%

Float: +84.4% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.0

Neutral momentum band

Price vs 200-day MA

-22.8%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

-0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALT stock rating?

Altimmune, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALT analysis?

The full report lives at /stocks/ALT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALT?

The latest report frames ALT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.